The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: A systematic review and meta-analysis of randomized controlled trials

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Xiong, Bo ^a   Wang, Chunbin ^a   Yao, Yuanqing ^a   Huang, Yuwen ^a   Tan, Jie ^a   Cao, Yin ^a   Zou, Yanke ^a   Huang, Jing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DOBUTAMINE; GLYCERYL TRINITRATE; NESIRITIDE; NITROPRUSSIDE SODIUM; PLACEBO; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ACUTE HEART FAILURE; ADVERSE OUTCOME; ARTICLE; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; WORSENING RENAL FUNCTION; BLOOD; DRUG EFFECTS; HEART FAILURE; KIDNEY; KIDNEY FUNCTION TEST; RENAL INSUFFICIENCY; RISK; STATISTICAL MODEL;

CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MODELS, STATISTICAL; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; RISK;

EID: 84939230883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131326     Document Type: Article

References (39)

1. Butler J, Chirovsky D, Phatak H, McNeill A, Cody R. Renal Function, Health Outcomes, and Resource Utilization in Acute Heart Failure A Systematic Review. Circ Heart Fail. 2010; 3(6):726-45. doi: 10. 1161/CIRCHEARTFAILURE.109.920298 PMID: 21081740
2. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of the kidney in heart failure. Eur Heart J. 2012; 33(17):2135-42. doi: 10.1093/eurheartj/ehs205 PMID: 22888113
3. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008; 51(13):1268-74. doi: 10.1016/j.jacc.2007.08.072 PMID: 18371557
4. van Deursen VM, Hernandez AF, Stebbins A, Hasselblad V, Ezekowitz JA, Califf RM, et al. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). Circulation. 2014; 130(12):958-65. doi: 10.1161/CIRCULATIONAHA.113.003046 PMID: 25074507
5. O'Connor C, Starling R, Hernandez A, Armstrong P, Dickstein K, Hasselblad V, et al. Effect of nesiritide in patients with acute decompensated heart failure. New Engl J Med. 2011; 365(1):32-43. doi: 10. 1056/NEJMoa1100171 PMID: 21732835
6. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005; 111(12):1487-91. PMID: 15781736
7. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013; 310(23):2533-43. doi: 10.1001/jama.2013.282190 PMID: 24247300
8. Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, et al. Impact of Nesiritide on Renal Function in Patients With Acute Decompensated Heart Failure and Pre-Existing Renal Dysfunction A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Am Coll Cardiol. 2007; 50 (19):1835-40. PMID: 17980248
9. Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC. Low Dose Nesiritide and the Preservation of Renal Function in Patients With Renal Dysfunction Undergoing Cardiopulmonary-Bypass Surgery A Double-Blind Placebo-Controlled Pilot Study. Circulation. 2007; 116(11 suppl):I-134-I-8.
10. Riter HG, Redfield MM, Burnett JC, Chen HH. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. 2006; 47(11):2334-5. PMID: 16750705
11. Yan B, Peng L, Zhao X, Chung H, Li L, Zeng L, et al. Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: An updated systematic review and cumulative meta-analysis. Int J Cardiol. 2014; 177(2):505-9. doi: 10.1016/j.ijcard.2014.08.078 PMID: 25183537
12. Mills RM, LeJemtel TH, Horton DP, Liang C-s, Lang R, Silver MA, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failureA randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol. 1999; 34(1):155-62. PMID: 10400005
13. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. New Engl J Med. 2000; 343(4):246-53. PMID: 10911006
14. Young JB, Abraham W, Stevenson L, Horton D, Elkayam U, Bourge R. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure-A randomized controlled trial. Jama- Journal of the American Medical Association. 2002; 287(12):1531-40.
15. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002; 144(6):1102-8. PMID: 12486437
16. Yancy CW, Singh A. Potential Applications of Outpatient< i> Nesiritide Infusions in Patients With Advanced Heart Failure and Concomitant Renal Insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] Trial). The American journal of cardiology. 2006; 98(2):226-9. PMID: 16828598
17. Yancy CW, Krum H, Massie BM, Silver MA, Stevenson LW, Cheng M, et al. Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart Failure Results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial. Circ Heart Fail. 2008; 1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483 PMID: 19808265
18. Zhao Q, Wu T-G, Lin Y, Li B, Luo J-Y, Wang L-X. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction. Heart Vessels. 2010; 25(2):97-103. doi: 10.1007/s00380-009-1171-0 PMID: 20339970
19. Chow SL, O'Barr SA, Peng J, Chew E, Pak F, Quist R, et al. Modulation of Novel Cardiorenal and Inflammatory Biomarkers by Intravenous Nitroglycerin and Nesiritide in Acute Decompensated Heart Failure An Exploratory Study. Circ Heart Fail. 2011; 4(4):450-5. doi: 10.1161/CIRCHEARTFAILURE. 110.958066 PMID: 21576282
20. Pan H-Y, Zhu J-H, Gu Y, Yu X-H, Pan M, Niu H-Y. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels. BMC Cardiovasc Disord. 2014; 14(1):31.
21. Fu S, Yi S, Zhu B, Wang L, Wang H, Bai Y, et al. Efficacy and safety of a modified dosage regimen of nesiritide in patients older than 75 years with acute heart failure. Aging Clin Exp Res. 2012; 24(5):524-9. doi: 10.3275/8295 PMID: 22395196
22. Owan TE, Chen HH, Frantz RP, Karon BL, Miller WL, Rodeheffer RJ, et al. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. J Card Fail. 2008; 14(4):267-75. doi: 10.1016/j.cardfail.2007.12.002 PMID: 18474338
23. Peacock WF, Emerman CL, Silver MA, Group PS. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. The American journal of emergency medicine. 2005; 23(3):327-31. PMID: 15915407
24. Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, et al. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail. 2011; 13(9):961-7. doi: 10.1093/eurjhf/hfr060 PMID: 21622980
25. Gassanov N, Biesenbach E, Caglayan E, Nia A, Fuhr U, Er F. Natriuretic peptides in therapy for decompensated heart failure. Eur J Clin Pharmacol. 2012; 68(3):223-30. doi: 10.1007/s00228-011-1117-1 PMID: 21901345
26. Colucci WS. Nesiritide for the treatment of decompensated heart failure. J Card Fail. 2001; 7(1):92-100. PMID: 11264555
27. Gnanaraj JF, von Haehling S, Anker SD, Raj DS, Radhakrishnan J. The relevance of congestion in the cardio-renal syndrome. Kidney Int. 2013; 83(3):384-91. doi: 10.1038/ki.2012.406 PMID: 23254894
28. Epstein FH, Levin ER, Gardner DG, Samson WK. Natriuretic peptides. New Engl J Med. 1998; 339 (5):321-8. PMID: 9682046
29. Houben AJ, Zander K, Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005; 19(4):411-9. PMID: 16011727
30. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol. 2001; 37(5):1221-7. PMID: 11300426
31. Munagala VK, Burnett JC, Redfield MM. The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol. 2004; 29(12):707-69. PMID: 15550914
32. Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, et al. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial. Circ Heart Fail. 2013; 6(5):1087-94. doi: 10.1161/CIRCHEARTFAILURE.113.000347 PMID: 24046475
33. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. The Lancet. 1998; 351(9095):47-52.
34. Legrand M, Jacquemod A, Gayat E, Collet C, Giraudeaux V, Launay J-M, et al. Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med. 2015; 41(1):68-76. doi: 10.1007/s00134-014-3566-3 PMID: 25465906
35. Lassus J, Harjola V-P. Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev. 2012; 17(2):251-61. doi: 10.1007/s10741-011-9242-6 PMID: 21431356
36. McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, et al. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction impact of the new chronic kidney disease-epidemiology collaboration group formula. Circ Heart Fail. 2012; 5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242 PMID: 22441773
37. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. New Engl J Med. 2012; 367(1):20-9. doi: 10.1056/NEJMoa1114248 PMID: 22762315
38. Inker LA, Shaffi K, Levey AS. Estimating Glomerular Filtration Rate Using the Chronic Kidney Disease- Epidemiology Collaboration Creatinine Equation Better Risk Predictions. Circ Heart Fail. 2012; 5 (3):303-6. doi: 10.1161/CIRCHEARTFAILURE.112.968545 PMID: 22589364
39. Tang WW, Dupont M, Hernandez AF, Voors AA, Hsu AP, Felker GM, et al. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial. JACC: Heart Failure. 2015; 3(1):40-9. doi: 10.1016/j.jchf.2014.06.014 PMID: 25453534